SynthesisBMC oral health2026
Systemic non-steroidal anti-inflammatory drugs as adjuncts in the treatment of chronic periodontitis: a systematic review and network meta-analysis.
Synthesis in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesSystematically evaluate the clinical efficacy of systemically administered non-steroidal anti-inflammatory drugs (NSAIDs) as an adjunct to scaling and root planing (SRP) for periodontitis, assess the therapeutic effects of different drugs, and identify the most effective treatment regimen. MATERIALS AND
methodsThis study is registered in PROSPERO under trial No. CRD420250651756. Randomized controlled trials (RCTs) examining systemic NSAIDs as SRP adjuncts were identified through systematic searches of PubMed, Embase, Web of Science, Cochrane Library and CNKI databases. Eligible studies were screened, followed by data extraction and risk-of-bias assessment using Cochrane criteria. Efficacy was assessed through changes in probing depth (PD) and clinical attachment loss (CAL). Statistical analyses were performed using Stata 18.0, and R 4.4.3 software.
resultsThirteen RCTs involving 549 patients met inclusion criteria. The results of the Network meta-analysis (NMA) identified that, when NSAIDs are used as an adjuvant treatment for periodontitis, compared with using only SRP to treat periodontitis, ibuprofen + SRP [MD = 0.58, 95% CI (0.31, 0.85)] shows the most significant efficacy in improving PD and CAL after 1 - month follow - up. At 3 months, the ibuprofen-doxycycline combination [MD = 1.70, 95% CI (1.16, 2.24)] and omega-3 polyunsaturated fatty acids (PUFAs) combined with aspirin [MD = 0.82, 95% CI (0.57, 1.07)] demonstrated superior efficacy versus monotherapies.
conclusionsCurrent evidence suggests that systemic administration of NSAIDs as an adjunct to periodontal baseline therapy may provide clinically significant benefits in periodontitis management. However, further well-designed randomized controlled trials with larger sample sizes are required to validate and refine this conclusion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.